Facebook
Twitter
Telegram
Report an ErrorZynerba Pharmaceuticals Financial Statements 2011-2024 | ZYNE
Annual Financial Statements Zynerba Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
18.8 M | 102 M | 94.3 M | 111 M | 77 M | 161 M | 154 M | 29.5 M | - | - | - | - |
Shares |
42.7 M | 39.3 M | 27 M | 22 M | 15.3 M | 12.9 M | 9.07 M | 4.46 M | - | - | - | - |
Historical Prices |
0.44 | 2.61 | 3.49 | 5.04 | 5.24 | 12.1 | 17.2 | 6.62 | - | - | - | - |
Net Income |
-35 M | -37.3 M | -51.3 M | -32.9 M | -39.9 M | -32 M | -23.4 M | -12.6 M | -5.67 M | -637 K | - | - |
Revenue |
- | - | - | - | 86 K | - | 7.25 K | 279 K | 810 K | 944 K | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | 279 K | 810 K | 944 K | - | - |
Operating Income |
-35.3 M | -36.8 M | -52.1 M | -34.3 M | -40.4 M | -32.8 M | -23.2 M | -12.5 M | -5.67 M | -634 K | - | - |
Interest Expense |
- | - | - | - | - | - | 80.2 K | 7.35 K | -1.84 K | -2.35 K | - | - |
EBITDA |
-35 M | -36.5 M | -51.9 M | -34.2 M | -40.3 M | -32.7 M | -23.1 M | -12.5 M | -5.64 M | -585 K | - | - |
Operating Expenses |
35.3 M | 36.8 M | 52.1 M | 34.3 M | 40.5 M | 32.8 M | 23.2 M | 12.8 M | 6.48 M | 1.58 M | - | - |
General and Administrative Expenses |
14.2 M | 15.3 M | 16.4 M | 13.9 M | 13.2 M | 10 M | 6.43 M | 5.36 M | 4.08 M | 444 K | - | - |
All numbers in USD currency
Quarterly Income Statement Zynerba Pharmaceuticals
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
50.2 M | 48.4 M | 47.9 M | 43.7 M | 41.4 M | 40.3 M | 41.2 M | 40.1 M | 40.1 M | 40.1 M | 29.3 M | 29.2 M | 26.1 M | 23.4 M | 23.2 M | 23.2 M | 22.1 M | 19.5 M | 17.6 M | 16.6 M | 13.5 M | 13.5 M | 13.4 M | 13.1 M | 13.1 M | 12.1 M | 9.68 M | 8.91 M | 8.86 M | 8.82 M | 8.79 M | 6.05 M | 1.45 M | 1.45 M | 1.46 M | 954 K | 660 K | 491 K | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-10.8 M | -10.1 M | - | -8.68 M | -9.85 M | -8.49 M | - | -10.6 M | -9.95 M | -7.96 M | -9.62 M | -9.05 M | -20.3 M | -12.3 M | -10.7 M | -1.95 M | -11.1 M | -9.15 M | -7.79 M | -7.81 M | -12 M | -12.3 M | -8.12 M | -8.31 M | -8.32 M | -7.26 M | -6.9 M | -5.98 M | -6.23 M | -4.28 M | -5.44 M | -3.99 M | -1.63 M | -1.49 M | -1.4 M | -2.52 M | -1.51 M | -240 K | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 86 K | - | - | - | - | - | - | - | - | - | - | 7.25 K | 49.3 K | 199 K | 15.4 K | 14.8 K | 74.2 K | 525 K | 64.1 K | 146 K | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-11.1 M | -10.5 M | - | -8.49 M | -9.17 M | -8.9 M | - | -10.2 M | -9.84 M | -7.88 M | -10.2 M | -9.23 M | -21.8 M | -10.8 M | -11.4 M | -1.93 M | -11.5 M | -9.47 M | -8.05 M | -7.99 M | -12 M | -12.4 M | -8.2 M | -8.55 M | -8.37 M | -7.7 M | -6.68 M | -6 M | -6.28 M | -4.24 M | -5.42 M | -4 M | -1.63 M | -1.49 M | -1.4 M | -2.51 M | -1.51 M | -239 K | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 76.9 K | 27 K | 22.7 K | -2.13 K | -10.8 K | 4.4 K | 1.57 K | 697 | 680 | - | -359 | -268 | -1.22 K | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | -10.4 M | - | -8.33 M | -9.05 M | -8.84 M | - | -10 M | -9.72 M | -7.82 M | -10.2 M | -9.17 M | -21.8 M | -10.8 M | -11.4 M | -1.89 M | -11.5 M | -9.44 M | -8.05 M | -7.96 M | -11.9 M | -12.4 M | -8.2 M | -8.52 M | -8.34 M | -7.68 M | -6.68 M | -5.97 M | -6.27 M | -4.23 M | -5.42 M | -3.99 M | -1.62 M | -1.49 M | -1.4 M | -2.51 M | -1.5 M | -239 K | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
11.1 M | 10.5 M | - | 8.49 M | 9.17 M | 8.9 M | - | 10.2 M | 9.84 M | 7.88 M | 10.2 M | 9.23 M | 21.8 M | 10.8 M | 11.4 M | 1.93 M | 11.5 M | 9.47 M | 8.13 M | 7.99 M | 12 M | 12.4 M | 8.2 M | 8.55 M | 8.37 M | 7.7 M | 6.68 M | 6 M | 6.28 M | 4.25 M | 5.47 M | 4.19 M | 1.64 M | 1.51 M | 1.48 M | 3.04 M | 1.57 M | 385 K | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
3.97 M | 3.39 M | - | 3.45 M | 3.72 M | 3.76 M | - | 3.87 M | 4.39 M | 3.28 M | 4.57 M | 3.43 M | 4.49 M | 3.92 M | 3.96 M | 3.53 M | 3.29 M | 3.16 M | 3.26 M | 3.13 M | 3.44 M | 3.42 M | 2.38 M | 2.8 M | 2.63 M | 2.21 M | 1.78 M | 1.49 M | 1.48 M | 1.68 M | 2.16 M | 1.92 M | 631 K | 654 K | 663 K | 2.11 M | 1.21 M | 99.7 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency